文献速递关节外科运动医学创伤骨科

股骨头缺损的骨软骨同种异体与自体移植:一项多中心研究

Osteochondral Allograft and Autograft Transplant for Femoral Head Defects: A Multicenter Study.
PubMed 文献 · Am J Sports Med · 2025-05-15

这项多中心病例系列(证据等级4)分析了27例股骨头缺损患者接受骨软骨同种异体移植(19例)或自体移植(8例)的临床与影像学结果。同种异体移植组平均随访2.8年,自体移植组9.5年,两组患者报告结局评分均较好;同种异体移植组4例(21.1%)平均1.9年转为全髋关节置换,自体移植组无转为全髋关节置换者。作者认为两种移植均应考虑用于局灶性股骨头缺损患者。

要点

  • 骨软骨同种异体移植与自体移植治疗股骨头缺损后患者报告结局评分总体较好。
  • 同种异体移植组4例(21.1%)平均1.9年转为全髋关节置换,自体移植组无转为全髋关节置换者。
  • 非原位股骨髁同种异体移植与股骨头同种异体移植的结局无显著差异。

核心结论

  • 骨软骨同种异体移植和自体移植治疗股骨头缺损总体显示出良好的临床结局和转为全髋关节置换的比例。
  • 非原位股骨髁同种异体移植显示出与股骨头同种异体移植相似的结局。
  • 作者认为,对于局灶性股骨头缺损患者,骨软骨同种异体移植和自体移植均应考虑。

研究设计与样本

  • 研究设计为病例系列,证据等级4。
  • 纳入2个机构所有接受骨软骨同种异体移植或自体移植治疗股骨头缺损的患者,共27例(同种异体移植19例,自体移植8例)。

主要发现

  • 同种异体移植组平均随访2.8年,自体移植组平均随访9.5年。
  • 同种异体移植组平均缺损大小为2.8×2.1 cm,自体移植组为1.6×1.0 cm。
  • 同种异体移植组平均mHHS、HOS-ADL、HOS-SSS和iHOT-12分别为86.7、92.8、81.4和79.0,自体移植组分别为87.6、92.7、83.1和82.0。
  • 股骨头同种异体移植与非原位股骨髁同种异体移植的患者结局无显著差异。
  • 同种异体移植组4例(21.1%)平均1.9年转为全髋关节置换;余15例同种异体移植患者中仅1例(6.7%)出现影像学骨关节炎进展;自体移植组无患者转为全髋关节置换。

关键数值与推荐

  • 临床结局采用改良Harris髋关节评分(mHHS)、髋关节结局评分-日常生活活动能力(HOS-ADL)、髋关节结局评分-运动特异性分量表(HOS-SSS)和国际髋关节结局工具(iHOT-12)评估。
  • 影像学采用Tönnis分级于术前和末次随访评估骨关节炎。

临床怎么用

  • 作者认为,对于局灶性股骨头缺损患者,骨软骨同种异体移植和自体移植均应考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteochondral allograft transplant and autograft transplant for femoral head defects have emerged as promising treatments for concomitant cartilage and subchondral bone injuries in young patients. PURPOSE: To evaluate the clinical and radiological outcomes of patients who underwent osteochondral allograft or autograft transplant for femoral head defects and identify any risk factors that may lead to conversion to total hip arthroplasty (THA). STUDY DESIGN: Case series; Level of evidence, 4. METHODS: All patients who underwent osteochondral allograft or autograft transplant for femoral head defects across 2 institutions were analyzed. Clinical outcomes were assessed at final follow-up with the modified Harris Hip Score (mHHS), Hip Outcome Score-Activities of Daily Living (HOS-ADL), Hip Outcome Score-Sport-Specific Subscale (HOS-SSS), and International Hip Outcome Tool (iHOT-12). Complications and reoperations were recorded. Patients were assessed radiographically preoperatively and at final follow-up for osteoarthritis using Tönnis grading. RESULTS: A total of 27 patients were included in this study (19 osteochondral allograft transplant, 8 osteochondral autograft transplant). The mean follow-up for the allograft and autograft cohorts was 2.8 and 9.5 years, respectively. The mean defect size for patients who underwent allograft and autograft transplant was 2.8 × 2.1 cm and 1.6 × 1.0 cm, respectively. The mean mHHS, HOS-ADL, HOS-SSS, and iHOT-12 for the allograft cohort were 86.7, 92.8, 81.4, and 79.0, respectively, and for the autograft cohort were 87.6, 92.7, 83.1, and 82.0, respectively. No significant difference in outcomes was noted for patients who underwent femoral head allograft versus nonorthotopic femoral condyle allograft transplant. For the allograft cohort, 4 patients (21.1%) underwent conversion to THA at a mean of 1.9 years. Of the remaining 15 allograft patients, only 1 patient (6.7%) had radiographic osteoarthritis progression. None of the patients in the autograft cohort underwent conversion to THA. CONCLUSION: Osteochondral allograft and autograft transplant for femoral head defects demonstrated overall favorable clinical outcomes and rates of conversion to THA. Additionally, nonorthotopic femoral condyle allografts demonstrated similar outcomes to femoral head allografts. Both osteochondral allograft and autograft transplant should be considered for patients with focal femoral head defects.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Clark SC, Nagelli CV, DeNovio A, et al. Osteochondral Allograft and Autograft Transplant for Femoral Head Defects: A Multicenter Study. Am J Sports Med. 2025. PMID: 40371749. doi:10.1177/03635465251338062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。